169 related articles for article (PubMed ID: 34128856)
1. A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
Jiang TY; Ren JJ; Zhang Y; Zhao Y; Feng XL
Medicine (Baltimore); 2021 Jun; 100(24):e26263. PubMed ID: 34128856
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
Luo F; Li L; Gao Q; Li YX
Medicine (Baltimore); 2021 Oct; 100(40):e27320. PubMed ID: 34622830
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment of prophylactic chemotherapy in treating with hydatidiform mole: A protocol for systematic review and meta-analysis.
Xu F; Zheng YL; Lu XY; Qiao HF; Wang Y
Medicine (Baltimore); 2021 Jun; 100(24):e26341. PubMed ID: 34128882
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
7. Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol.
Branco-Silva M; Maesta I; Elias K; Berkowitz RS; Abbade JF; Horowitz NS
BMJ Open; 2022 Feb; 12(2):e059484. PubMed ID: 35210351
[TBL] [Abstract][Full Text] [Related]
8. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
11. Evaluation on curative effects of adjuvant chemotherapy alone in treating with advanced endometrial carcinoma: A protocol for systematic review and meta-analysis.
Jiang J; Chen L; Tian Y
Medicine (Baltimore); 2022 Mar; 101(9):e28817. PubMed ID: 35244039
[TBL] [Abstract][Full Text] [Related]
12. Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhang T; Guo Y; He X; Hou M; Wang L; An R; Gao L
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):636-644. PubMed ID: 38282348
[TBL] [Abstract][Full Text] [Related]
13. Clinical therapeutic effects of platelet-rich plasma in patients with burn wound healing: A protocol for systematic review and meta-analysis.
Li J; Hu WP; Zhong G
Medicine (Baltimore); 2021 Aug; 100(31):e26404. PubMed ID: 34397792
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease: A protocol for systematic review and meta-analysis.
Li K; Liu MM; Yang X; Chen L; Geng H; Luo W; Ma J
Medicine (Baltimore); 2021 Jun; 100(24):e26340. PubMed ID: 34128881
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
Jareemit N; Horowitz NS; Goldstein DP; Berkowitz RS; Elias KM
Gynecol Oncol; 2020 Dec; 159(3):751-757. PubMed ID: 33023756
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficiency of antibiotics in treating adult patients with symptomatic apical periodontitis: A protocol for systematic review and meta-analysis.
Luo W; Yan H; Guo S
Medicine (Baltimore); 2021 Jun; 100(25):e26405. PubMed ID: 34160426
[TBL] [Abstract][Full Text] [Related]
17. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
18. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Albright BB; Ellett T; Knochenhauer HE; Goins EC; Monuszko KA; Kaplan SJ; Previs RA; Moss HA; Havrilesky LJ; Davidson BA
BJOG; 2023 Apr; 130(5):443-453. PubMed ID: 36648416
[TBL] [Abstract][Full Text] [Related]
19. First line chemotherapy in low risk gestational trophoblastic neoplasia.
Alazzam M; Tidy J; Hancock BW; Osborne R
Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficiency of peptide receptor radionuclide therapy in patients with metastatic prostate carcinoma: A protocol for systematic review and meta-analysis.
Liu G; Tang T; Liu XP; Zhou ZH; Li FJ
Medicine (Baltimore); 2021 Apr; 100(17):e25612. PubMed ID: 33907113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
